Status: Recruiting
A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
The purpose of this study is to evaluate how long guselkumab remains in participants with moderate to severe crohn's disease (CD) or ulcerative colitis (UC) in real-world setting. CD and UC are Inflammatory bowel disease, a group of inflammatory conditions of the colon and small intestine.
Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Janssen-Cilag A.G., SwitzerlandUpdated: Jun 12, 2026Locations: 1
Eligibility criteria
Must be eligible for biologic treatment and initiate guselkumab according to the... [+2]
Contraindicated to guselkumab per the label [+4]